Freight pressure and a loading response
High ocean-freight rates hurt margins; a floating crane commissioned in October enabled larger Capesize vessels. The loss also included a non-cash impairment charge.
Bauxite Hills more than doubled annual shipments over this five-year record. The financial turning point came in stages: gross profit turned positive, operating cash recovered, and statutory profit followed. Expansion, freight exposure and debt financing explain that path—but the final year’s profit also contains substantial accounting gains.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Actual shipments, not capacity.
Sales after cost of sales, before other items.
Before financing-classified interest and lease principal.
Drawn facilities less cash; excludes lease obligations.
Metro is a bauxite producer with one reportable operating segment. This review follows the link from mined and shipped tonnes to sales margins, then cash and financing. It does not substitute future nameplate capacity for actual output.
The early losses were not simply a lack of sales. In FY2021, high freight rates squeezed delivered margins and an impairment charge deepened the loss. The subsequent investment in loading and transhipping capacity was central to the recovery.
The final-year result needs two separate readings: cash generation improved, while impairment reversal, foreign-exchange gains and tax benefits also lifted statutory profit. Neither the higher profit nor low reported net debt removes the need to review debt maturities and lease payments.
High ocean-freight rates hurt margins; a floating crane commissioned in October enabled larger Capesize vessels. The loss also included a non-cash impairment charge.
The board approved a pathway to 7 million WMT annual capacity. Weather, costs and missed volume plans weighed on results; the equity raise included debt conversion as well as new funds.
Metro established its 50% Ikamba joint venture and financed expansion through a US$30m/A$45m Nebari facility. The terminal’s arrival and commissioning belonged to the following year.
Ikamba began operations in April and the screening circuit followed in May. Shipments rose, although wet weather disrupted the season; an equity raise and refinancing supported the balance sheet.
Shipment growth and stronger operating cash accompanied a statutory profit containing impairment reversal and tax benefits. Temporary transhipping and loading interruptions still affected deliveries.
The shipment series gives the sales story its physical scale. Mined and shipped tonnes are deliberately separate: stock movements and season timing prevent them from being interchangeable. The source describes revenue recognition at vessel loading, with final price reconciliation after discharge.
Million wet metric tonnes
AI-generated presentation · values from Bauxite Hills: mined tonnes and shipped tonnes; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Sales grew; gross profit turned positive before statutory profit; no missing values plotted as zero.
Million wet metric tonnes
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Bauxite mined | 3.034 | 3.193 | 4.613 | 5.644 | 6.291 |
| Bauxite shipped | 2.798 | 3.412 | 4.567 | 5.684 | 6.174 |
Source volumes are thousands of wet metric tonnes, converted to million WMT. FY2021 scale is established by the saved Key Statistics qualification, not the shortened unit label alone.
Mined and shipped volumes differ with inventory and operating timing. These are actual annual volumes, not the 7 Mtpa expanded capacity or future guidance.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Bauxite revenue | 160.137 | 177.895 | 235.840 | 307.337 | 378.362 |
| Cost of sales | (189.946) | (209.056) | (222.376) | (271.063) | (307.587) |
| Gross profit / (loss) | (29.809) | (31.161) | 13.464 | 36.274 | 70.775 |
| Administration expense | (5.696) | (6.334) | (8.844) | (11.150) | (16.763) |
| Operating profit / (loss) before interest and tax | (91.121) | (36.606) | 5.071 | 25.205 | 99.851 |
| Finance costs | (6.875) | (13.393) | (16.008) | (22.836) | (20.617) |
| Profit / (loss) before tax | (96.344) | (50.122) | (13.482) | (22.001) | 114.787 |
| Profit / (loss) after tax | (105.500) | (50.122) | (13.482) | (22.001) | 142.334 |
Signed expenses and losses are in parentheses. FY2023 uses the FY2024 comparative for cost of sales, gross profit and administration: the earlier edition shows 222.461, 13.379 and 8.668 respectively versus 222.376, 13.464 and 8.844 here; total operating profit and net loss are unchanged.
FY2021 loss includes A$55.686m impairment expense. FY2025 operating profit includes the A$47.738m impairment reversal; neither is an underlying earnings measure.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 gross profit improved as revenue grew faster than total cost of sales. Within that bill, production and royalties rose while ocean freight fell. Beyond gross profit, the impairment reversal and favourable foreign-exchange movement were large contributors; the income-tax benefit lifted net profit further.
A$ million
AI-generated presentation · values from Sales grew; gross profit turned positive before statutory profit; no missing values plotted as zero.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Production expenses | 167.934 | 198.218 |
| Royalties | 38.022 | 50.760 |
| Ocean freight | 45.522 | 31.943 |
| PPE depreciation | 8.508 | 14.365 |
| Right-of-use depreciation | 9.520 | 10.105 |
| Marketing | 1.557 | 2.196 |
| Total cost of sales | 271.063 | 307.587 |
Expense magnitudes are positive here, unlike the signed income-statement row. No unit-cost ratio is inferred from mixed freight, royalty and depreciation components.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Gross profit | 70.775 |
| Impairment reversal | 47.738 |
| Operating profit (includes reversal) | 99.851 |
| Finance costs | (20.617) |
| Finance income | 0.135 |
| Foreign-exchange gain | 35.418 |
| Profit before tax | 114.787 |
| Income-tax benefit | 27.547 |
| Profit after tax | 142.334 |
A selected reconciliation view: gross profit, operating profit and profit before/after tax are nested subtotals, not amounts to add together. Administration and other operating charges are already within operating profit.
The tax benefit and impairment reversal are accounting effects, not customer cash receipts. The statutory profit is not presented as recurring cash earnings.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Operating cash turned positive before the Group returned to statutory profit. Expansion required PPE and joint-venture contributions, while financial-assurance deposits were another cash demand. The full cash-flow view distinguishes these uses from borrowing repayments and lease principal.
The FY2022 raising narrative includes loan conversion, so headline capital raised is not equated to customer receipts or cash share proceeds. A separate FY2024 cash-versus-conversion discrepancy in the saved records is retained in the table notes rather than silently reconciled.
A$ million
AI-generated presentation · values from Five-year cash-flow record; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net operating cash flow | (17.641) | (1.187) | 12.316 | 46.638 | 75.055 |
| Net investing cash flow | (3.673) | (6.694) | (36.307) | (37.538) | (23.073) |
| Net financing cash flow | 9.162 | 7.624 | 23.963 | 12.235 | (33.671) |
| Closing cash and cash equivalents | 13.883 | 11.746 | 12.070 | 31.192 | 57.463 |
Financing is positive in FY2021 despite a generic extracted “used in” label. Its cash-flow context establishes a net inflow.
Interest paid and lease principal are classified in financing. Operating cash flow is therefore not cash remaining after those obligations. Currency effects also change closing cash.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Receipts from customers | 145.216 | 190.245 | 226.872 | 315.201 | 379.376 |
| Suppliers and employees | (163.044) | (192.624) | (214.618) | (268.686) | (304.321) |
| PPE cash purchases | (0.234) | (2.691) | (11.564) | (17.149) | (10.768) |
| Exploration/evaluation cash payments | (0.455) | (0.156) | (0.894) | (0.228) | (0.874) |
| Security-bond cash payments | (0.180) | (3.847) | (12.131) | (8.237) | (10.469) |
| Cash-flow statement: share-issue proceeds | 25.580 | 21.081 | 0.000 | 45.000 | 0.000 |
| Borrowing repayments | (1.125) | (0.515) | (2.500) | (39.220) | (23.269) |
| Cash interest paid | (4.464) | (7.075) | (3.998) | (13.132) | (9.262) |
| Lease principal payments | (9.511) | (14.005) | (13.211) | (13.270) | (9.186) |
FY2023 share proceeds use the later comparative showing nil; the original extraction incorrectly repeats the financing subtotal in that line. FY2024 cash-flow statement reports A$45m share proceeds while a separate raising narrative describes A$5m loan conversion within a A$45m raise. This saved-data conflict is disclosed; no second cash adjustment is imposed.
Additional cash paid to equity-accounted investments was A$11.718m in FY2023, A$11.924m in FY2024 and A$0.962m in FY2025. These amounts are included in investing totals, not PPE cash purchases.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Equity recovered sharply by FY2025, alongside stronger cash and asset remeasurement. But current liabilities still exceeded current assets and part of the financing burden sits in leases rather than the issuer’s net-debt metric. The later maturity extension is kept outside the December balance sheet.
Ikamba is a 50%-owned, equity-accounted joint venture and also supplies a bareboat-chartered terminal. Investment in the venture, the Group’s right-of-use asset and lease obligations therefore describe different accounting relationships, not duplicated cash purchases of one asset.
A$ million
AI-generated presentation · values from Consolidated assets, liabilities and equity; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Current assets | 40.622 | 22.832 | 35.310 | 56.415 | 89.601 |
| Current liabilities | 46.914 | 73.534 | 89.486 | 101.177 | 106.840 |
| Property, plant and equipment | 79.385 | 79.423 | 86.792 | 99.615 | 149.609 |
| Right-of-use assets | 31.073 | 22.083 | 22.782 | 44.195 | 40.297 |
| Total assets | 152.266 | 129.527 | 168.997 | 243.206 | 361.371 |
| Total liabilities | 110.273 | 110.588 | 159.044 | 202.602 | 174.500 |
| Total equity | 41.993 | 18.939 | 9.953 | 40.604 | 186.871 |
Liabilities are shown as positive balances throughout; the FY2022 extraction presents them in parentheses. Consolidated, not parent-only, figures are used.
The FY2025 asset increase includes reinstated PPE impairment value and A$28.327m deferred tax assets; it is not all new physical investment.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Unrestricted cash and equivalents | 13.883 | 11.746 | 12.070 | 31.192 | 57.463 |
| Current borrowings | 1.167 | 35.585 | 33.322 | 23.704 | 45.597 |
| Non-current borrowings | 34.596 | 2.536 | 46.075 | 51.457 | 13.294 |
| Current lease liabilities | 9.929 | 7.912 | 12.495 | 9.195 | 4.603 |
| Non-current lease liabilities | 21.670 | 13.581 | 9.246 | 25.743 | 26.478 |
Net debt reported for FY2025 was A$1.428m (FY2024: A$43.969m): drawn loan facilities less cash. This does not subtract leases, trade creditors or all other liabilities.
At December 2025 current liabilities exceeded current assets. The February 2026 senior-debt maturity extension is a subsequent event, not a revision to these balance-date amounts. Restricted cash of A$5.302m at FY2025 is separate from the cash row.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.